Home -- Symptoms -- Cycles -- A Tentative Interpretation of Lyme Flare Cycles and a Corresponding Therapy
In particular, researchers have been able to mathematically model and often verify in vivo or in vitro the following possible states of the infection [Dibrov et al. 1976 , Dibrov et al.1978, McKenzie and Bossert 1997, Muraille et al. 1996, DeBoer et al. 1993]
In this work a mathematical model accompanies intuition and eventually leads to a rationale for the duration of antibiotic treatment:
Assumption
The detailed microbiologic and immunologic processes (as e.g. reviewed by Rupprecht et al., 2008) work together to produce the overall, observable behavior ("clinical picture").
Method of model formulation
Applying the above mentioned established procedures used in constructing mathematical models of infections, we have reproduced this behavior with
In the next paragraph I will specify my choice of the clinical picture.
J.J. Burrascano recommended his patients
to "keep a carefully detailed daily diary of their symptoms to help judge
the effects of treatment, the presence of the classic four week cycle,
and treatment endpoint" [Burrascano 1997].
We took
Data processing
Borrelia burgdorferi (Bb) might suppress the specific immune response in several ways, which results in :
The period of the oscillation -measured as e.g. the average time between any two successive flares- is typical of the mechanism behind the oscillation.
My statistical analysis was marginally accurate enough to reveal that the period of the flare cycles depended on what type of antibiotic we used [Gruber 1999, lengths of cycles].
This assumption of a synchronized pathogen population is in contradiction to experimental findings: Even if all cells of a bacteria population start out cell-dividing at the same time ("in synchrony with each other"), they lose that synchronization over time. i.e. they get out of step with each other and their cell divisions eventually become statistically distributed over time.
Niches
We know such niches very well from other illnesses: When the root of a tooth gets heavily infected, our immune system cannot eliminate the pathogen entirely, and we have to live with an encapsulated infection -which we feel as pain. The infection is being held in check by the immune system. Thus, the sinus-maxillary floor is a compartment under poor immune surveillance. To get rid of the floor's infection we need to access it mechanically, i.e. operate on it from outside.
Type 2 niches, the one Bb
produces itself, are of a chemical and microbiologic nature. Bb
The Clinical Picture: The Symptom List and Statistical Analysis
As long as our laboratory diagnostic
techniques sometimes produce results that seem to be inconsistent with
our clinical findings, the information the ill person is able to provide
about the status of his/her disease needs to be discussed.
as starting points for our symptom list.
To visualize possible cyclical symptoms occurrence,
(For more details than given below see my summary report ["Evaluation of ...", Gruber 1999a] or my draft ["Compartment Model displaying ...", Gruber 1999b])
2. Borrelia burgdorferi Outer Surface Proteins Stimulate a Periodic Immune Response
(deutsche Übersetzung)
Basics of Flare Cycle Interpretation
Because of immune response suppression (1) or the missing memory effect (2), our immune system gets locked into undamped "feedback oscillations" (also called "self-organized oscillations") in its attempt to eliminate the antigen. As long as Osp's are seen by our immune system, it keeps eliminating them, but it doesn't do so continuously. Here is my interpretation of why it works intermittendly. (To simplify description, mainly effect (2) will be considered. Effect (1) works similarly.)
(more)
When the sizes of the Osp populations in the niches become negligible, our immune system may eventually stop cleaning out the Osp's (in my cleaning crew example: the crew may no longer be needed).
One reason for this dependence might be that different antibiotics access the niches to a different degree, causing the release of a different amount of Osp's. If there is a larger amount of Osp's within the niche, it may release more of them into compartments under immune surveillance than when there are only few Osp's in the niche. In our cleaning crew analogy, an aggressive antibiotic liberating a large amount of Osp's could be compared with a steady flow of trucks stirring up continuously a lot of dust in the street. To catch up with the larger amount of dust entering our house from the street, the cleaning crew will have to come within shorter periods.
Cleaning Crew vs. Generation Cycle
Thus, I interpret the periodic flare cycles much like a periodic appearance of a cleaning crew in a building. When only a small amount of dust enters the building every day, the crew doesn't need to come so often. When a long series of trucks stirrs up a lot of dust in the street in front of our house, the crew has to come more often to keep the dust level in the house within acceptable limits.
Nevertheless, both interpretations suggest the same timing for an antibiotic pulse treatment "Take antibiotics at the time a flare is experienced."
2.1 Niches
Osp on (live or dead) borreliae may reside in niches, leak from these and enter the compartments under immune surveillance. Niches are e.g. compartments poorly accessible to the immune system or antibiotic, but they can be more than that: By definition
The protection may wane with time and so will the size of the spirochete or toxin population residing in the niche.
Type 1 and Type 2 Niches
Type 1 niches, the ones provided by the host, are sites within our bodies that are poorly accessible to antibiotics and normal immune surveillance (see e.g. Fallon and Nields 1994 and literature cited therein).
In my model simulating the flare cycles in the presence of antibiotics, I'm referring to either type 1 or type 2 niches. The basic concept underlying the model is that the niche needs to have the following properties:
For short I will characterize the latter compartments as "visible" to the immune system or to antibiotics. These are the compartments in which we feel the Lyme symptoms (flares). There are many types of symptoms as there are many such compartments [Gruber 1999 lengths of cycles]. But saying this, I do not imply a one-to-one relationship between symptom and compartment.
It is known that the sensitivity of the immune system changes throughout the menstrual cycle. M. Barkley et al. [1997] found that in women the immune response varies with the clock frequency of the menstrual cycle. I assume that the immune system is more sensitive to the inflammation caused by Osp in the luteal phase. So, the presence of antigen is more "annoying" sometimes than at other times, and this "sometimes" is mostly in the luteal phase. The physician Charlene DiMarco made some comments in an email to me, stating that when her patients' health improved they noticed their symptoms worsening after their menses, whereas at the onset of Lyme they observed the opposite: their symptoms improved during that same period of their menstrual cycle.
3. Rationale for a Conservative Treatment Duration
My tentative interpretation of the switch from "self-organized" to "menstrual cycle driven" is that it is the intensity of the infection that causes the switch.
About 30 medical professionals at the Leiden University Medical Center, Leiden, The Netherlands, who participated in one of my seminars in March 1999, agreed on the following mechanism responsible for the symptom cycles:
"Some cell wall constituents released by B. burgdorferi belong to the class of TI-1 antigens. The immune system does not produce memory cells upon contact with and after successful elimination of TI-1 antigens. Thus, each new encounter with them produces an identical immune response, leading to a chain of periodic immune responses that continues as long as there is a persistent source of antigen in the host. "It has been shown that B. burgdorferi has developed strategies to survive the attack of the immune system and of antibiotics [Brorson 1997, Liegner 1993, Preac Mursic 1996, Zhang 1997].
Research to clarify the background is rapidly progressing.
References
Ball P,
The self-made tapestry: pattern formation in nature, Oxford University
Press, Oxford, New York, Tokyo, 1999.
Barkley
M, Harris N, Szantyr B, The Lyme Urine Antigen Test (LUAT) during antibiotic
therapy in women with recurrent menstrual cycles. 10th Annual Int. Conf.
on Lyme
Borreliosis, National Institute
of Health, Bethesda, MD, April 28-30, 1997 (http://www.igenex.com/newsset1.htm).
Bleiweiss JD, When to suspect Lyme disease, early 1990's (http://cassia.org/essay.htm).
Brorson O, Brorson SH, Transformation of cystic forms of Borrelia burgdorferi to normal, mobile spirochetes. Infection 25(4):240-6, 1997 (http://www.Lymenet.de/literatur/niches.htm#Brorson O, Brorson SH, APMIS 1998 Dec;106(12):1131-41).
Burrascano JJ, Managing Lyme disease: diagnostic hints and treatment guidelines for Lyme borreliosis, in: Conn's Current Therapy - Latest Approved Methods of Treatment for the Practicing Physician, pp.140-143, Harcourt Brace & Company, 1997 (http://www.ilads.org/burrascano_1102.htm).
Chambers HF, Hadley WK, Jawetz E, "Beta-lactam antibiotics & other inhibitors of cell wall synthesis", pages 725-726 in: Basic & Clinical Pharmacology (Katzung BG, ed.), Appleton & Lange, Stamford, CT, USA, 1998.
De Boer RJ, Perelson AS, Kevrekidis IG, Immune network behavior--I. From stationary states to limit cycle oscillations, 1993 (http://www.lymenet.de/literatur/immundif.htm#De Boer RJ, Perelson AS, Kevrekidis IG, 1993).
Dibrov BF, Livshits MA, Vol'kenshtein MV, Mathematical model of the immune response, 1976 (http://www.Lymenet.de/literatur/immunsys.htm#Dibrov BF, Livshits MA, Vol'kenshtein MV, 1976).
Dibrov BF, Livshits MA, Vol'kenshtein MV, Mathematical model of the immune response. IV. Threshold character of the infectious process, 1978 (http://www.lymenet.de/literatur/immunsys.htm#Dibrov BF, Livshits MA, Vol'kenshtein MV, 1978).
Fallon BA, Nields JA, Microbiology of Borrelia burgdorferi, in: "Lyme Disease: A Neuropsychiatric Illness", an overview, The American Journal of Psychiatry 151,11:1571-1583, 1994 (http://www.Lymenet.de/literatur/microbiology.htm).
Grier T, The Difficulty of Culturing Spirochetes, http://www.lymealliance.org/medical/lab/lab_7.php
Gruber J, Evaluation of the long-term inflammation in neuroborreliosis, 1999 (http://www.Lymenet.de/symptoms/cycles/evalsum.htm).
Gruber J, Compartment Model Displaying Symptom Cycles, 1999
Kroun M, A pilot study on granulated cellular structures and other abnormal microscopy findings in blood from chronically ill persons, York, June 20, 2003.
Lawrence
C, Lipton RB, Lowy FD, Coyle PK, Seronegative chronic relapsing neuroborreliosis.
Eur Neurol 35(2):113-117, 1995.
Liegner
KB, Lyme disease: the sensible pursuit of answers. J Clin Microbiol
31(8):1961-1963, 1993 (http://www.lymeinfo.net/sensiblepursuit.html).
Mattman,
LH, Cell Wall Deficient Forms - Stealth Pathogens, 2nd. ed., CRC Press,
1993
McKenzie
FE, Bossert WH, The dynamics of Plasmodium falciparum blood-stage infection,
1997 (http://www.lymenet.de/literatur/immundif.htm#McKenzie
FE, Bossert WH, 1997).
Muraille
E, Thieffry D, Leo O, Kaufman M, Toxicity and neuroendocrine regulation
of the immune response: a model analysis, 1996 (http://www.lymenet.de/literatur/immundif.htm#Muraille
E, Thieffry D, Leo O, Kaufman M, 1996).
Mursic
VP, Wanner G, Reinhardt S, Wilske B, Busch U, Marget W, Formation and
cultivation of Borrelia burgdorferi spheroplast-L-form variants, Infection,
May-Jun;24(3):218-26, 1996 (http://www.Lymenet.de/literatur/niches.htm#Mursic
VP, Wanner G, Reinhardt S et al 1996).
Phillips
SE, Mattman LH, Hulinska D, Moayad H, A proposal for the reliable culture
of Borrelia burgdorferi from patients with chronic Lyme disease, even from
those previously aggressively treated, Infection 26 364-367, 1998 (http://www.Lymenet.de/literatur/niches.htm#Phillips
SE, Mattman LH, Hulinska D, Moayad H 1998).
Preac-Mursic
V, Weber K, Pfister HW, Wilske B, Gross B, Baumann A, Prokop J, Survival
of Borrelia burgdorferi in antibiotically treated patients with Lyme borreliosis.
Infection, Nov-Dec;17(6):355-9, 1989 (http://www.Lymenet.de/literatur/niches.htm#Preac-Mursic
V, Weber K, Pfister HW 1989).
Mathematical
immune response models, literature survey, April 2000 (http://www.Lymenet.de/literatur/immunsys.htm).
Sanders,
CC, Das veränderliche Bild der mikrobiellen Resistenz, Continuing
Education 1996, E4-X005: 1-8, Bristol-Myers Squibb Company, Route 206 &
Providence Line, Princeton, NJ 08543, USA, Tel.: (001) 609 - 252-5141 (http://www.Lymenet.de/literatur/abstracts.htm#sanders).
Schutzer
SE, Coyle PK, Dunn JJ, Luft BJ, Brunner M, Early and specific antibody
response to OspA in Lyme Disease. J Clin Invest Jul;1994(1):454-457, 1994
(http://www.Lymenet.de/literatur/niches.htm#Schutzer
SE, Coyle PK, Dunn JJ, Luft BJ, Brunner M 1994).
Models of immune
sytems
- The use of differential equations, a literature survey, April 2000 (http://www.Lymenet.de/literatur/immundif.htm).
Zhang
JR, Hardham JM, Barbour AG, Norris SJ, Antigenic variation in Lyme
disease borreliae by promiscuous recombination of VMP-like sequence cassettes,
Cell Apr 18;89(2):275-285, 1997 (http://www.Lymenet.de/literatur/abstracts.htm#zhang).
version: January 12, 2019
Address
of this page
Home
Send comments to Joachim
Gruber.